Compare AbCellera Biologics Inc (ABCL) vs GE Vernova Inc (GEV) Price & Performance

AbCellera Biologics IncTrade

GE Vernova IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs GE Vernova Inc — how do they compare? AbCellera Biologics Inc trades at $9.05 (market cap $2.99B), while GE Vernova Inc trades at $1,026.43 (market cap $269.50B). The key difference: GE Vernova Inc is far larger — about 90.1× AbCellera Biologics Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

	ABCL	GEV
Market Cap	$2.99B	$269.50B
Sector	Health	Technology
52-Week High	$9.76	$1.17K
52-Week Low	$2.78	$547.96
Enterprise Value	$2.58B	$259.17B
Dividend Yield	—	0.2%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABCL

View details →

GEV

GE Vernova benefits from AI-driven power and grid bottlenecks but faces high expectations at 28x 2028 earnings.Seeking Alpha · 7 hours agoNeutral Invesco S&P 500 Equal Weight Energy ETF rated Buy for balanced energy sector exposure amid oil market shifts.Seeking Alpha · 1 day agoBullish View details →

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.